BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29452601)

  • 1. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study.
    Tuttolomondo A; Petta S; Casuccio A; Maida C; Corte VD; Daidone M; Di Raimondo D; Pecoraro R; Fonte R; Cirrincione A; Zafonte R; Cabibi D; Cammà C; Di Marco V; Licata A; Magliozzo F; Marchesini G; Merlino G; Craxì A; Pinto A
    Cardiovasc Diabetol; 2018 Feb; 17(1):28. PubMed ID: 29452601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness.
    Sunbul M; Agirbasli M; Durmus E; Kivrak T; Akin H; Aydin Y; Ergelen R; Yilmaz Y
    Atherosclerosis; 2014 Dec; 237(2):490-3. PubMed ID: 25463079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.
    Long MT; Wang N; Larson MG; Mitchell GF; Palmisano J; Vasan RS; Hoffmann U; Speliotes EK; Vita JA; Benjamin EJ; Fox CS; Hamburg NM
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1284-91. PubMed ID: 25745056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension.
    Catena C; Bernardi S; Sabato N; Grillo A; Ermani M; Sechi LA; Fabris B; Carretta R; Fallo F
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):389-93. PubMed ID: 22796347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
    Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
    Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness.
    Li N; Zhang GW; Zhang JR; Jin D; Li Y; Liu T; Wang RT
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):218-23. PubMed ID: 25456154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in arterial stiffness and microcirculatory function between Black and White Americans.
    Morris AA; Patel RS; Binongo JN; Poole J; Al Mheid I; Ahmed Y; Stoyanova N; Vaccarino V; Din-Dzietham R; Gibbons GH; Quyyumi A
    J Am Heart Assoc; 2013 Apr; 2(2):e002154. PubMed ID: 23568343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population.
    Yu XY; Zhao Y; Song XX; Song ZY
    J Zhejiang Univ Sci B; 2014 Oct; 15(10):879-87. PubMed ID: 25294377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation index association with reactive hyperemia as assessed by peripheral arterial tonometry in hypertension.
    Yang WI; Park S; Youn JC; Son NH; Lee SH; Kang SM; Jang Y
    Am J Hypertens; 2011 Nov; 24(11):1234-8. PubMed ID: 21901014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
    Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.
    Petta S; Argano C; Colomba D; Cammà C; Di Marco V; Cabibi D; Tuttolomondo A; Marchesini G; Pinto A; Licata G; Craxì A
    J Hepatol; 2015 Apr; 62(4):928-33. PubMed ID: 25445395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.
    Weinstein G; Davis-Plourde K; Himali JJ; Zelber-Sagi S; Beiser AS; Seshadri S
    Liver Int; 2019 Sep; 39(9):1713-1721. PubMed ID: 31155826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular index.
    Chung GE; Choi SY; Kim D; Kwak MS; Park HE; Kim MK; Yim JY
    Medicine (Baltimore); 2015 Mar; 94(12):e654. PubMed ID: 25816034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations of digital vascular function, cardiovascular risk factors, and arterial stiffness: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) cohort study.
    Brant LC; Hamburg NM; Barreto SM; Benjamin EJ; Ribeiro AL
    J Am Heart Assoc; 2014 Dec; 3(6):e001279. PubMed ID: 25510401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals.
    Kim BJ; Kim NH; Kim BS; Kang JH
    Cardiology; 2012; 123(1):54-61. PubMed ID: 22986520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study.
    Vodkin I; Valasek MA; Bettencourt R; Cachay E; Loomba R
    Aliment Pharmacol Ther; 2015 Feb; 41(4):368-78. PubMed ID: 25496369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes.
    Chou CY; Yang YC; Wu JS; Sun ZJ; Lu FH; Chang CJ
    Diab Vasc Dis Res; 2015 Sep; 12(5):359-65. PubMed ID: 26008803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.